Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALGIPED: lysine ibuprofen vs ibuprofen for acute pain in children
2022-002436-31Phase 4Withdrawn
- Sponsor
- Dicofarm
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Ibuprofen L-lysine and ibuprofen in acute pain (2 arms), sponsored by Dicofarm. Primary endpoint: Primary pain reduction at 5 minutes. Planned start Nov 2022; status: withdrawn.
02
Drugs
Ibuprofen L-lysineibuprofen
03
Conditions
acute pain
Beyond the preview
Go deeper on 2022-002436-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002436-31.